Bumper Offer - Urjas oil Just @ Rs. 1
Oflaquin 400 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Oflaquin 400 Mg Tablet is used -
Severe
Moderate
Mild
Is the use of Oflaquin 400 Mg Tablet safe for pregnant women?
Oflaquin can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Oflaquin right away. Take your doctor's advice before taking it again.
Is the use of Oflaquin 400 Mg Tablet safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Oflaquin. Immediately discontinue Oflaquin if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Oflaquin 400 Mg Tablet on the Kidneys?
Very few cases of side effects of Oflaquin on kidney have been reported.
What is the effect of Oflaquin 400 Mg Tablet on the Liver?
Very few cases of side effects of Oflaquin on the liver have been reported.
What is the effect of Oflaquin 400 Mg Tablet on the Heart?
Oflaquin is rarely harmful for the heart.
Oflaquin 400 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Mild
If you are suffering from any of the following diseases, you should not take Oflaquin 400 Mg Tablet unless your doctor advises you to do so -
Is this Oflaquin 400 Mg Tablet habit forming or addictive?
No, there is no any evidence that Oflaquin 400 Mg Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Oflaquin 400 Mg Tablet, you should not drive or work on any heavy machine, as Oflaquin 400 Mg Tablet can make you drowsy.
Is it safe?
Oflaquin 400 Mg Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Oflaquin 400 Mg Tablet for mental disorders.
Interaction between Food and Oflaquin 400 Mg Tablet
Oflaquin 400 Mg Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Oflaquin 400 Mg Tablet
Taking alcohol with Oflaquin 400 Mg Tablet can be dangerous.
Oflaquin should be taken with a meal. Drink plenty of fluids while you are taking this medicine. Drinking extra water will help prevent some unwanted effects of this medicine. Do not take this medicine along with milk, yogurt, or other dairy products, it may reduce the absorption of a drug. Take it exactly as directed by the physician.
Do not take Oflaquin along with milk. It reduces the effectiveness of medicine by reducing the absorption of a drug. Please consult your doctor before consuming this medicine with milk.
Oflaquin is a broad-spectrum antibiotic, active against both Gram-positive and Gram-negative bacteria. It works by inhibiting the bacterial cell division and stops the working of enzyme which is responsible for cell division. It is effective against a large number of bacteria, even those bacteria which are resistant to other drugs.
No, Oflaquin does not contain penicillin. It is an antibiotic that belongs to the class of medication called fluoroquinolone. It used to treat several types of bacterial infection such as such as bronchitis, pneumonia, urinary, respiratory, skin, gastrointestinal, anthrax, bone, and eye infections.
Oflaquin is a brand name of ofloxacin. It is a prescription drug that belongs to the class of medication called fluoroquinolones. It is a broad spectrum antibiotic, used for treating bacterial infections, such as bronchitis, pneumonia, urinary, respiratory, skin, gastrointestinal, anthrax, bone, and eye infections.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
